On Friday, 89bio Inc (NASDAQ: ETNB) opened higher 4.70% from the last session, before settling in for the closing price of $7.44. Price fluctuations for ETNB have ranged from $6.57 to $16.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -11.14% at the time writing. With a float of $99.24 million, this company’s outstanding shares have now reached $105.91 million.
The firm has a total of 70 workers. Let’s measure their productivity. In terms of profitability, gross margin is 79.91%, operating margin of -81736.75%, and the pretax margin is -72869.23%.
89bio Inc (ETNB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 89bio Inc is 6.30%, while institutional ownership is 96.55%. The most recent insider transaction that took place on Apr 01 ’24, was worth 575,153. In this transaction Chief Executive Officer of this company sold 52,718 shares at a rate of $10.91, taking the stock ownership to the 459,171 shares. Before that another transaction happened on Mar 04 ’24, when Company’s Director bought 1,350,000 for $15.35, making the entire transaction worth $20,722,500. This insider now owns 12,431,584 shares in total.
89bio Inc (ETNB) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.45 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.53) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.00% during the next five years compared to -11.24% drop over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Check out the current performance indicators for 89bio Inc (ETNB). In the past quarter, the stock posted a quick ratio of 13.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.97, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.53 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Analysing the last 5-days average volume posted by the [89bio Inc, ETNB], we can find that recorded value of 0.48 million was lower than the volume posted last year of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 65.84%. Additionally, its Average True Range was 0.41.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 26.42%, which indicates a significant decrease from 97.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.21% in the past 14 days, which was lower than the 58.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.13, while its 200-day Moving Average is $9.38. Now, the first resistance to watch is $7.97. This is followed by the second major resistance level at $8.16. The third major resistance level sits at $8.50. If the price goes on to break the first support level at $7.44, it is likely to go to the next support level at $7.10. Now, if the price goes above the second support level, the third support stands at $6.91.
89bio Inc (NASDAQ: ETNB) Key Stats
There are currently 98,384K shares outstanding in the company with a market cap of 825.04 million. Presently, the company’s annual sales total 0 K according to its annual income of -142,190 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -47,970 K.
